Sannanine, a new cytotoxic alkaloid from Streptomyces sannanensis

Journal of Antibiotics

Volumn 62, Issue 11, 2009, Pages 647-648

  Li, Yiqing ^a   Zheng, Dan ^b   Li, Jun ^a   Han, Li ^b   Cui, Xiaolong ^a   Lang, Li ^b   Li, Minggang ^a   Wang, Zhanyou ^b   Zhao, Jiangyuan ^a   Huang, Xueshi ^b  

^a YUNNAN UNIVERSITY   (China)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Alkaloid; Cytotoxicity; Sannanine; Streptomyces sannanensis

Indexed keywords

ALKALOID; LAVENDAMYCIN; QUINOLINE 5,8 DIONE DERIVATIVE; RUFOCROMOMYCIN; SANNANINE; STREPTONIGRONE; UNCLASSIFIED DRUG;

ARTICLE; BGC 823 CELL; CELL STRAIN HEPG2; CHINA; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG ISOLATION; DRUG STRUCTURE; FERMENTATION; H460 CELL; HUMAN; HUMAN CELL; IC 50; NUCLEOTIDE SEQUENCE; PANC 1 CELL; PHYLOGENY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOIL MICROFLORA; STREPTOMYCES; STREPTOMYCES SANNANENSIS; TUMOR CELL LINE;

ALKALOIDS; ANTIBIOTICS, ANTINEOPLASTIC; CELL LINE, TUMOR; FERMENTATION; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; QUINOLONES; QUINONES; STREPTOMYCES;

STREPTOMYCES SANNANENSIS;

EID: 72449171987     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.1038/ja.2009.95     Document Type: Article

References (10)

1. Choi, H. Y., Kim, D. W., Chi, D. Y., Yoon, E. Y. & Kim, D. J. Preparation of 7-alkylamino- 2-methylquinoline-5,8-diones. J. Org. Chem. 67, 5390-5393 (2002).
2. Behforouz, M., Haddad, J., Cai, W. & Gu, Z. X. Chemistry of quinoline-5,8-diones. J. Org. Chem. 63, 343-346 (1998).
3. Herlt, A. J., Rickards, R. W. & Wu, J. P. The structure of streptonigrone, and a comment on the biosynthesis of the streptonigrin antibiotics. J. Antibiot. 38, 516-518 (1985).
4. Yoshida, K., Ishiguro, M., Honda, H., Yamamoto, M. & Kubo, Y. Regioselevtive 6-amination and 6-arylation of 5, 8-quinolinedione promoted by metal irons. Bull.Chem. Soc. Jpn. 61, 4335-4340 (1988).
5. Porter, T. H., Bowman, C. M. & Folkers, K. Antimetabolites of coenzyme Q. 16.new alkylmercaptoquinones having antimalarial curative activity. J. Med. Chem. 16, 115-118 (1973).
6. Take, Y., Oogose, K., Kubo, T. & Inouye, Y. Comparative study on biological activities of heterocyclic quinines and streptonigrin. J. Antibiot. 40, 679-684 (1987).
7. Lazo,J.S.et al. Discovery and biological evaluation of a new family of potent inhibitors of the dual specificity protein phosphatase Cdc25. J. Med. Chem. 44, 4042-4049 (2001).
8. Podeszwa,B. et al. Investigating the antiproliferative activity of quinoline-5,8-diones and styrylquinolinecarboxylic acids on tumor cell lines. Bioorg. Med. Chem. Lett. 17, 6138-6141 (2007).
9. Hsu, T. S. et al. 7-Chloro-6- piperidin-1-yl-quinoline-5,8-dione (PT-262), a novel synthetic compound induces lung carcinoma cell death associated with inhibiting ERK and CDC2 phosphorylation via a p53-independent pathway. Cancer Chemother.Pharmacol. 62, 799-808 (2008).
10. Carmichael, J., DeGraff, W. G., Gazdar, A. F., Minna, J. D. & Mitchell, J. B. Evaluation of a tetrazoliumbased semiautomated colorimetric assay: Assessment of chemosensitivity testing. Cancer Res. 47, 936-942 (1987). (Pubitemid 17027905)